1. Clinical dose-response relationship of fluticasone propionate in adults with asthma. Issue 1 (23rd December 2003) Authors: Masoli, M; Weatherall, M; Holt, S; Beasley, R Journal: Thorax Issue: Volume 59:Issue 1(2004) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M4 The impact of an asthma inreach service on asthma management and follow up. (14th November 2013) Authors: Taylor, L; Castell, B; Willis-Chan, J; O'Shea, M; Masoli, M Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Issue 9 (31st August 2005) Authors: Masoli, M; Weatherall, M; Holt, S; Beasley, R Journal: Thorax Issue: Volume 60:Issue 9(2005) Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Optimal starting dose of inhaled corticosteroids in adult asthma: why has it taken so long?. Issue 2 (28th January 2005) Authors: Masoli, M; Weatherall, M; Beasley, R Journal: Thorax Issue: Volume 60:Issue 2(2005) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P114 Difficult asthma: the Plymouth experience. (2nd December 2011) Authors: Castell, B; Pike, D; Masoli, M Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P157 Severe asthma questionnaire (SAQ): validation and continuing use. (12th November 2019) Authors: Lanario, J; Hyland, M; Jones, R; Masoli, M Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P167 The contribution of extra-pulmonary symptoms of quality of life in severe asthma are important and may be overlooked. (12th November 2019) Authors: Lanario, J; Hyland, M; Wei, Y; Jones, R; Masoli, M Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P196 A new questionnaire to measure quality of life in severe asthma (saq): preliminary validation. (15th November 2017) Authors: Jones, R; Masoli, M; Hyland, M; Lanario, J Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P19 Impact of month of initiation of omalizumab on treatment of severe allergic asthma, a sub-analysis of the apex ii study. (15th November 2017) Authors: Niven, R; Saralaya, D; Chaudhuri, R; Masoli, M; Clifton, I; Mansur, AH; Hollywood, S; McLain-Smith, S; Menzies-Gow, A Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S91 Fungal sensitisation and bronchiectasis in a severe asthma clinic. (14th November 2013) Authors: Hayes, G; Masoli, M; Whalley, B; Jones, R; Hyland, M Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗